Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Lung Fung Group HoldingsHKSE:02290 -1.86%17 EBITDA Margin % is 18.17% as of Mar. 2026, which is 0% above its 10-year median of 18.11. GuruFocus rates HKSE:02290 with a GF Score™ of 17/100. The stock has 5 warning signs investors should review. Among 1,130 Retail - Cyclical companies, Lung Fung Group Holdings ranks better than 81.86% on this metric.
Lung Fung Group Holdings (HKSE:02290) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Lung Fung Group Holdings EBITDA Margin % Related Terms
Lung Fung Group Holdings EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lung Fung Group Holdings EBITDA Margin % Chart
Lung Fung Group Holdings Annual Data
Trend
Mar23
Mar24
Mar25
Mar26
EBITDA Margin %
12.38
18.20
18.04
18.17
Lung Fung Group Holdings Semi-Annual Data
Mar23
Mar24
Mar25
Mar26
EBITDA Margin %
12.38
18.20
18.04
18.17
HKSE:02290 vs DDS: EBITDA Margin % Comparison
For the Department Stores subindustry, Lung Fung Group Holdings's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Lung Fung Group Holdings EBITDA Margin % vs Retail - Cyclical Industry
For the Retail - Cyclical industry and Consumer Cyclical sector, Lung Fung Group Holdings's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Lung Fung Group Holdings's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lung Fung Group Holdings (HKSE:02290) has a EBITDA Margin % of 18.17% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Lung Fung Group Holdings and its competitors. This is near median its historical median of 18.11. Over the past decade, Lung Fung Group Holdings' EBITDA Margin % has ranged from 12.38 to 18.20. According to the industry distribution chart, Lung Fung Group Holdings ranks #205 out of 1130 companies in the Retail - Cyclical industry, placing it in the top 18.1%.
Is Lung Fung Group Holdings' EBITDA Margin % too high?
Lung Fung Group Holdings' current EBITDA Margin % of 18.17% is near median its 10-year median of 18.11. Over the past 10 years, this metric has ranged from a low of 12.38 to a high of 18.20. The Retail - Cyclical industry median EBITDA Margin % is 7.58. Lung Fung Group Holdings' value of 18.17% is 139.7% above this industry median. Based on the distribution chart, Lung Fung Group Holdings ranks #205 out of 1130 companies in the Retail - Cyclical industry, which is in the top quartile — a strong position relative to peers. Overall, Lung Fung Group Holdings has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Lung Fung Group Holdings' EBITDA Margin % compare to DDS?
According to the Retail - Cyclical industry distribution chart, Lung Fung Group Holdings ranks #205 out of 1130 companies for EBITDA Margin %. This places Lung Fung Group Holdings in the top 18% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 7.58. Lung Fung Group Holdings' value of 18.17% is 139.7% above this benchmark. Historically, Lung Fung Group Holdings' own EBITDA Margin % has ranged from 12.38 to 18.20 over the past decade. While the company's 10-year median is 18.11 vs. the industry median of 7.58, Lung Fung Group Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Retail - Cyclical company?
The median EBITDA Margin % among Retail - Cyclical companies is 7.58, based on 1,130 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Lung Fung Group Holdings's current EBITDA Margin % of 18.17% is 139.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Lung Fung Group Holdings and its competitors. For the Retail - Cyclical industry, the median EBITDA Margin % is 7.58 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Lung Fung Group Holdings's current EBITDA Margin % is 18.17%, which is near median its own 10-year median of 18.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lung Fung Group Holdings stock overvalued right now?
Lung Fung Group Holdings (HKSE:02290) has a current EBITDA Margin % of 18.17%. The current EBITDA Margin % is 18.17%, which is near median its 10-year median of 18.11 and 139.7% above the Retail - Cyclical industry median of 7.58. Lung Fung Group Holdings' overall GF Score™ is 17/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Lung Fung Group Holdings (HKSE:02290), the current EBITDA Margin % is 18.17% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Lung Fung Group Holdings Ltd is an investment holding company. Along with its subsidiaries, the company operates as a Hong Kong-based chain retail store of beauty, health and pharmaceutical products under the 'Lung Fung' brand. It principally engaged in the sales of a wide variety of beauty products, health products, pharmaceutical products and other consumer goods such as household and daily essentials and food products. The majority of revenue is derived from the sales of Beauty products through retail stores located in Hong Kong.
17GF Score
Get the complete analysis for HKSE:02290
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02290 has been successfully added to your 
